Shares of CVS Health Co. (NYSE:CVS – Get Rating) have been given a consensus recommendation of “Moderate Buy” by the twenty-five brokerages that are covering the firm, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, sixteen have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among brokers that have covered the stock in the last year is $117.86.
Several brokerages have weighed in on CVS. Royal Bank of Canada lowered their price target on CVS Health from $119.00 to $115.00 and set an “outperform” rating for the company in a report on Monday. Tigress Financial raised their price target on CVS Health from $125.00 to $130.00 in a report on Wednesday, August 17th. JPMorgan Chase & Co. reduced their price objective on CVS Health from $130.00 to $125.00 and set an “overweight” rating for the company in a research note on Thursday, November 3rd. Credit Suisse Group raised their price objective on CVS Health from $113.00 to $117.00 and gave the stock an “outperform” rating in a research note on Monday, August 8th. Finally, StockNews.com started coverage on CVS Health in a research note on Wednesday, October 12th. They issued a “strong-buy” rating for the company.
CVS Health Price Performance
Shares of NYSE CVS opened at $99.91 on Friday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.69 and a current ratio of 0.94. The company has a market cap of $131.28 billion, a PE ratio of 42.51, a P/E/G ratio of 1.59 and a beta of 0.69. The business has a 50-day simple moving average of $96.77 and a two-hundred day simple moving average of $96.91. CVS Health has a fifty-two week low of $86.28 and a fifty-two week high of $111.25.
CVS Health Announces Dividend
Institutional Trading of CVS Health
Institutional investors have recently bought and sold shares of the business. Advisor Resource Council acquired a new stake in shares of CVS Health in the second quarter worth approximately $795,000. Brown Advisory Inc. boosted its stake in shares of CVS Health by 11.9% in the second quarter. Brown Advisory Inc. now owns 315,888 shares of the pharmacy operator’s stock worth $29,980,000 after acquiring an additional 33,520 shares during the last quarter. Eastern Bank boosted its stake in shares of CVS Health by 2.2% in the second quarter. Eastern Bank now owns 6,917 shares of the pharmacy operator’s stock worth $640,000 after acquiring an additional 149 shares during the last quarter. Equitable Trust Co. boosted its stake in shares of CVS Health by 2.7% in the first quarter. Equitable Trust Co. now owns 7,114 shares of the pharmacy operator’s stock worth $720,000 after acquiring an additional 186 shares during the last quarter. Finally, Dowling & Yahnke LLC boosted its stake in shares of CVS Health by 2.9% in the first quarter. Dowling & Yahnke LLC now owns 66,534 shares of the pharmacy operator’s stock worth $6,734,000 after acquiring an additional 1,858 shares during the last quarter. 77.64% of the stock is owned by institutional investors and hedge funds.
CVS Health Company Profile
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.
- Get a free copy of the StockNews.com research report on CVS Health (CVS)
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don’t Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
- Vision Hydrogen, Now Vision Energy, Puts Hopes In Stock Split
- Coupang Stock And Why You Should Care
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.